Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial - Yahoo Finance
DXD Etf | USD 24.64 0.17 0.69% |
About 54% of ProShares UltraShort's investor base is interested to short. The current sentiment regarding investing in ProShares UltraShort Dow30 etf implies that many traders are impartial. The current market sentiment, together with ProShares UltraShort's historical and current headlines, can help investors time the market. In addition, many technical investors use ProShares UltraShort etf news signals to limit their universe of possible portfolio assets.
ProShares UltraShort etf news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of ProShares daily returns and investor perception about the current price of ProShares UltraShort Dow30 as well as its diversification or hedging effects on your existing portfolios.
ProShares |
Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial Yahoo Finance
Read at news.google.com
ProShares UltraShort Fundamental Analysis
We analyze ProShares UltraShort's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProShares UltraShort using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProShares UltraShort based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
ProShares UltraShort is currently under evaluation in probability of bankruptcy as compared to similar ETFs. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
ProShares UltraShort Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ProShares UltraShort etf to make a market-neutral strategy. Peer analysis of ProShares UltraShort could also be used in its relative valuation, which is a method of valuing ProShares UltraShort by comparing valuation metrics with similar companies.
Peers
ProShares UltraShort Related Equities
SKF | ProShares UltraShort | 2.02 | ||||
DOG | ProShares Short | 0.31 | ||||
TWM | ProShares UltraShort | 0.05 | ||||
SDS | ProShares UltraShort | 0.42 | ||||
QID | ProShares UltraShort | 1.62 |
Check out ProShares UltraShort Hype Analysis, ProShares UltraShort Correlation and ProShares UltraShort Performance. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
The market value of ProShares UltraShort is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares UltraShort's value that differs from its market value or its book value, called intrinsic value, which is ProShares UltraShort's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares UltraShort's market value can be influenced by many factors that don't directly affect ProShares UltraShort's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares UltraShort's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares UltraShort is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares UltraShort's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.